A medical workers classifies blood groups at the stem cell bank of the Blood Transfusion and Haematology Hospital in HCM City (Photo: VNA)
A ceremony was held in central Da Nang city on August 21 to mark the 20th anniversary of the first blood stem cell transplant (BSCT) in Vietnam, which laid the cornerstone of peripheral and umbilical cord blood stem cell transplants in the country.
The first operation was a bone marrow stem cell transplant conducted at the Blood Transfusion and Haematology Hospital in Ho Chi Minh City in July 1995.
Nine facilities specialising in BSCT have been established nationwide so far, and they performed 445 BSCT operations, including 185 cases by the HCM City Blood Transfusion and Haematology Hospital.
The hospital’s Director Phu Chi Dung said the success of the BSCT therapy has helped many patients with acute blood diseases to fully recover and return to the normal life. However, these operations in Vietnam still face certain difficulties such as inadequate equipment and high expenses as they are not covered by health insurance.
Addressing the ceremony, Deputy Minister of Health Nguyen Thi Xuyen said the study on and application of stem cells have opened up bright prospects of curing patients with acute diseases.
She asked the HCM City Blood Transfusion and Haematology Hospital and the National Institute of Haematology and Blood Transfusion to step up the training of high-quality personnel as well as cooperation with other countries to gain experiences in studying and applying stem cells in treatment.-VNA
Le Kieu Diem, 40, diagnosed with breast cancer was discharged from Hue General Hospital in stable condition on February 13, becoming the third cases successfully treated with stem cell therapy at the Hue General Hospital so far.
The first non-relative umbilical cord blood transplant was successfully conducted in Vietnam, announced the National Institute of Hematology and Blood Transfusion (NIHBT) under the Ministry of Health on April 2.
Since the first stem cell transplant (SCT) was successfully performed in 1995 at the Blood Transfusion and Haematology Hospital (BT-H) in Ho Chi Minh City, Vietnam has performed a total of 387 cases of SCT to date; among them, 218 were autologous SCT while the remaining were allogeneic SCT.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.